Krystal Biotech share price today
(NASDAQ: KRYS)

Name: Krystal Biotech Share Price Today (NASDAQ: KRYS) - Krystal Biotech Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Krystal Biotech share price is $155.06 & ₹13,411.14 as on 24 Jan 2025, 2.30 'hrs' IST

$155.06

▲

1.6

(1.04%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Krystal Biotech share price in Dollar and Rupees. Guide to invest in Krystal Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Krystal Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Krystal Biotech share price movements

Today's Low: $149.34
Today's High: $155.19
$155.06
3.69%
Downside
Day's Volatility :3.77%
Upside
0.08%
52 Weeks Low: $107.50
52 Weeks High: $219.34
$155.06
30.67%
Downside
52 Weeks Volatility :50.99%
Upside
29.31%

Krystal Biotech Returns

Period	Krystal Biotech Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-12.56%	-5.5%	0.0%
6 Months	-28.18%	-4.3%	0.0%
1 Year	27.15%	1.6%	0.0%
3 Years	172.09%	9.8%	-11.0%

Krystal Biotech Key Statistics

in dollars & INR

Previous Close	$153.46
Open	$151.16
Today's High	$155.19
Today's Low	$149.335
Market Capitalization	$4.4B
Today's Volume	$235.7K
52 Week High	$219.34
52 Week Low	$107.5
Revenue TTM	$241.5M
EBITDA	$69.1M
Earnings Per Share (EPS)	$1.77
PE Ratio	85.62
Profit Margin	21.68%
Quarterly Earnings Growth YOY	-0.67%
Return On Equity TTM	6.38%

How to invest in Krystal Biotech Stock (KRYS) from India?

It is very easy for Indian residents to invest directly in Krystal Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Krystal Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Krystal Biotech or KRYS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Krystal Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Krystal Biotech shares which would translate to 0.006 fractional shares of Krystal Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Krystal Biotech, in just a few clicks!

Returns in Krystal Biotech for Indian investors in Rupees

Investment Value

₹1,00,000

Krystal Biotech investment value today

Current value as on today

₹1,32,532

Returns

₹32,532

(+32.53%)

Returns from Krystal Biotech Stock

₹28,478 (+28.48%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Krystal Biotech

-41%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Krystal Biotech on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -41% less investors are searching Krystal Biotech in the last 30 days versus the previous period.

Global Institutional Holdings in Krystal Biotech

FMR Inc
14.93%
BlackRock Inc
13.88%
Vanguard Group Inc
9.91%
venBio Select Advisor LLC
9.12%
State Street Corp
5.05%
Capital World Investors
3.06%

Analyst Recommendation on Krystal Biotech

Buy

94%Buy

5%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Krystal Biotech(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Krystal Biotech

What analysts predicted

Upside of 33.01%

Target:

$206.25

Current:

$155.06

Insights on Krystal Biotech

Price Movement
In the last 3 years, KRYS stock has moved up by 177.6%
KRYS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 40.5% return, outperforming this stock by 22.8%
Price to Sales
ForKRYS every $1 of sales, investors are willing to pay $18.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.1 for every $1 of sales.

Krystal Biotech Technicals Summary

Sell

Neutral

Buy

Krystal Biotech is currently in a neutral trading position according to technical analysis indicators.

Krystal Biotech Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Krystal Biotech Inc	-4.38%	-28.18%	27.15%	172.09%	165.69%
Biontech Se	0.91%	34.01%	18.85%	-26.4%	246.9%
Regeneron Pharmaceuticals, Inc.	-4.82%	-36.95%	-28.33%	12.74%	100.35%
Vertex Pharmaceuticals Incorporated	4.86%	-13.58%	-0.46%	88.45%	88.24%
Alnylam Pharmaceuticals, Inc.	9.57%	13.5%	44.91%	103.56%	127.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Krystal Biotech Inc	85.62	85.62	NA	5.23	0.06	0.05	NA	30.81
Biontech Se	160.8	NA	0.04	-3.33	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	17.02	17.02	1.05	44.99	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.1	0.48	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Krystal Biotech Inc	Buy	$4.4B	165.69%	85.62	21.68%
Biontech Se	Buy	$28.1B	246.9%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.6B	100.35%	17.02	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$110.2B	88.24%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$34.2B	127.75%	NA	-15.86%

About Krystal Biotech

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Organization	Krystal Biotech
Employees	229
CEO	Mr. Krish S. Krishnan M.B.A., M.S.
Industry	Health Technology

Management People of Krystal Biotech

Name	Title
Mr. Krish S. Krishnan M.B.A., M.S.	Founder, Chairman, President & CEO
Ms. Suma M. Krishnan	Founder, President of R&D and Director
Ms. Kathryn A. Romano CPA	Executive VP & Chief Accounting Officer
Mr. John Thomas	General Counsel & Corporate Secretary
Mr. John Karakkal	Vice President of North American Sales & Marketing
Ms. Christine Wilson	Head of U.S. Sales & Marketing
Dr. Stephane Paquette Ph.D.	Vice President of Corporate Development
Mr. Josh Suskin	Director of Human Resources & Operations
Mr. Laurent Goux	Senior VP & GM of Europe
Mr. David Chien	Senior Vice President of Clinical Development

Important FAQs about investing in Krystal Biotech (KRYS) from India :

What is Krystal Biotech share price today?

Krystal Biotech share price today stands at $155.06, Open: $151.16 ; Previous Close: $153.46 ; High: $155.19 ; Low: $149.34 ; 52 Week High: $219.34 ; 52 Week Low: $107.50. The stock opens at $151.16, after a previous close of $153.46. The stock reached a daily high of $155.19 and a low of $149.34, with a 52-week high of $219.34 and a 52-week low of $107.50.

Can Indians buy Krystal Biotech shares?

Yes, Indians can invest in the Krystal Biotech (KRYS) from India.

With INDmoney, you can buy Krystal Biotech at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Krystal Biotech at zero transaction cost.

How can I buy Krystal Biotech shares from India?

It is very easy to buy Krystal Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Krystal Biotech be purchased?

Yes, you can buy fractional shares of Krystal Biotech with INDmoney app.

What are the documents required to start investing in Krystal Biotech stocks?

To start investing in Krystal Biotech, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.